跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
biased agonists
首页
药物
biased agonists
biased agonists
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Biased adrenergic agonists
申请人: UNIV SOUTH FLORIDA
优先权: 2022
US
Interferon-gamma biased agonists
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2019
US
HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS
申请人: ICAHN SCHOOL MED MOUNT SINAI
优先权: 2024
WO
HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS
申请人: ICAHN SCHOOL MED MOUNT SINAI
优先权: 2021
EP
US
WO
3 件公开
Signaling-biased mu opioid receptor agonists
申请人: SCRIPPS RESEARCH INST
优先权: 2017
US
SELECTIVE, PARTIAL, AND ARRESTIN-BIASED 5-HT2A AGONISTS WITH UTILITY IN VARIOUS DISORDERS
申请人: SAINT JOSEPHS UNIV
优先权: 2022
US
Beta-arrestin-biased cannabinoid CB1 receptor agonists and methods for making and using them
申请人: THE UNIV OF NORTH CAROLINA AT GREENSBORO
优先权: 2016
US
2 件公开
BETA CARBOLINE ANALOGUES AS SELECTIVE AND BIASED KAPPA OPIOID RECEPTORS AGONISTS FOR TREATING VARIOUS ASSOCIATED PATHOPHYSIOLOGICAL CONDITIONS
申请人: COUNCIL SCIENT IND RES
优先权: 2022
EP
US
WO
3 件公开
药物
反馈